Houghton R L, Dillon D C, Molesh D A, Zehentner B K, Xu J, Jiang J, Schmidt C, Frudakis A, Repasky E, Maltez Filho A, Nolasco M, Badaro R, Zhang X, Roche P C, Persing D H, Reed S G
Corixa Corporation, 1124 Columbia St., Ste 200, Seattle, WA 98104, USA.
Mol Diagn. 2001 Jun;6(2):79-91. doi: 10.1007/BF03262038.
We used a combination of genetic subtraction, silicon DNA microarray analysis, and quantitative PCR to identify tissue- and tumor-specific genes as diagnostic targets for breast cancer.
From a large number of candidate antigens, several specific subsets of genes were identified that showed concordant and complementary expression profiles. Whereas transcriptional profiling of mammaglobin resulted in the detection of 70% of tumors in a panel of 46 primary and metastatic breast cancers, the inclusion of three additional markers resulted in detection of all 46 specimens. Immunomagnetic epithelial cell enrichment of circulating tumor cells from the peripheral blood of patients with metastatic breast cancer, coupled with RT-PCR-based amplification of breast tumor-specific transcripts, resulted in the detection of anchorage-independent tumor cells in the majority of patients with breast cancer with known metastatic disease.
Complementation of mammaglobin with three additional genes in RT-PCR increases the detection of breast cancers in tissue and circulating tumor cells.
我们采用基因消减、硅基DNA微阵列分析和定量PCR相结合的方法,来鉴定组织特异性和肿瘤特异性基因,作为乳腺癌的诊断靶点。
从大量候选抗原中,鉴定出了几个特定的基因子集,它们表现出一致且互补的表达谱。乳腺珠蛋白的转录谱分析在一组46例原发性和转移性乳腺癌中检测出70%的肿瘤,而加入另外三个标志物后则检测出了全部46个标本。对转移性乳腺癌患者外周血中的循环肿瘤细胞进行免疫磁珠上皮细胞富集,并结合基于逆转录-聚合酶链反应(RT-PCR)的乳腺肿瘤特异性转录本扩增,在大多数已知有转移疾病的乳腺癌患者中检测到了不依赖贴壁生长的肿瘤细胞。
在RT-PCR中,乳腺珠蛋白与另外三个基因互补,可提高在组织和循环肿瘤细胞中对乳腺癌的检测率。